Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » MSK Study Suggests Germline Tests May Miss Mosaic Cancer Risk Mutations in Some Patients

MSK Study Suggests Germline Tests May Miss Mosaic Cancer Risk Mutations in Some Patients

Nov 18, 2020
|
Andrea Anderson
Premium

NEW YORK – A small subset of unselected cancer patients may carry risky germline variants in some, but not all, of their cells — cancer susceptibility mosaicism that may lead to missed pathogenic or likely pathogenic variants on available germline genetic tests, according to research presented Tuesday at the Association for Molecular Pathology virtual annual meeting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Featured Webinar

Five Things to Consider When Ordering NIPT

Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms. 

What's Popular?

In Sequencing

  1. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  2. China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

  3. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  4. Nonalcoholic Fatty Liver Disease Progression Can Be Traced by Gene Expression Signature

  5. Depression-Related Gut Microbiome, Metabolite Changes Lead to Potential Biomarker Set

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.